<DOC>
	<DOCNO>NCT01225055</DOCNO>
	<brief_summary>Spinal cord injury ( SCI ) result mark acute loss bone . This study evaluate effect teriparatide ( PTH ) use vibration form mechanical stimulation bone mass .</brief_summary>
	<brief_title>Effect Teriparatide , Vibration Combination Bone Mass Bone Architecture Chronic Spinal Cord Injury</brief_title>
	<detailed_description>The aim study evaluate PTH vibration group individual chronic SCI loss bone mass low extremity . A convenience sample 60 subject SCI enrol 12 month study assess effect PTH ( 20 ug/day ) vibration ( 10 min/day ) individually combination BMD bone marker . Subjects evaluate 3 , 6 , 9 , 12 month initiate treatment measurement bone density well bone marker formation resorption .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Age &gt; 21 year ( must close epiphysis ; PTH contraindicate epiphysis open ) Both male female SCI inability ambulate independently Capable position DXA perform Low bone mass total hip DEXA ( Z score &lt; 1.5 ; T score &lt; 2.5 T score &lt; 2.0 plus preexist fragility fracture ) Capable read understanding inform consent document Able selfadminister teriparatide someone family No known endocrinopathies Normal TSH level Normal 25OH vitamin D level ( &gt; 30ng/ml ) Normal calcium level Normal renal function ( creatinine &lt; 2.0mg/dl ) Able return followup visit Surgical intervention result metal anatomy preclude obtain DXA measurement ( e.g. , cardiac pacemaker , ferromagnetic implant brain aneurysm clip ) . Had allergic reaction Teriparatide ( FORTEO ) one ingredient . Have Paget 's disease bone Have unexplained high level f alkaline phosphatase blood Any active Gastrointestinal condition result malabsorption History presence alcoholism drug abuse within 2 year prior study screen Other medical condition opinion investigator would preclude subject complete study History malignancy . Patients basal cell carcinoma successfully remove allow enroll protocol . History radiation therapy Unable selfadminister PTH administer Elevated liver function test &gt; 2x normal Currently prescribe anticonvulsant Currently prescribe glucocorticoid , inhaled glucocorticoid Currently prescribe boneactive agent , include bisphosphonate , raloxifene , hormone therapy ( estrogen estrogen/progestin ) , calcitonin strontiumcontaining compound . Bisphosphonate use allow time initiation study medication dose study medication . Previous history PTH use Pregnant , plan become pregnant , lactate</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>